Retrospective analysis between PD-L1 expression and prognosis for stage III non-small cell lung cancer patients

被引：0
|
作者：
Tokito, Takaaki [1 ]
Azuma, Koichi [1 ]
Ishii, Hidenobu [1 ]
Yamada, Kazuhiko [1 ]
Hoshino, Tomoaki [1 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3-1-3
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [41] Evaluate soluble PD-L1 in plasma in advanced stage non-small cell lung cancer patients
    Nhung Pham
    Quyet Do
    Thang Ta
    Dung Nguyen
    Dai Do
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [42] High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
    Okuma, Yusuke
    Hishima, Tsunekazu
    Kashima, Jumpei
    Homma, Sadamu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (03) : 495 - 505
  • [43] High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
    O, Y.
    Hishima, Tsunekazu
    Kashi, Jumpei
    Homma, Sadamu
    CANCER SCIENCE, 2018, 109 : 1099 - 1099
  • [44] High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
    Yusuke Okuma
    Tsunekazu Hishima
    Jumpei Kashima
    Sadamu Homma
    Cancer Immunology, Immunotherapy, 2018, 67 : 495 - 505
  • [45] Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study
    de Castro, Nicoly Marques
    Moura, Fernando
    Hada, Aline Lury
    Garcia, Diogo
    Victor, Elivane da Silva
    Schvartsman, Gustavo
    Carvalho, Leonardo
    Fernandes, Milena Lourenco Coleta
    Martins, Rodrigo de Souza
    da Silva, Elaine Ferreira
    dos Santos, Sarah Silva Mello Batista
    Taniwaki, Leticia
    Taranto, Patricia
    Pontes, Janaina
    Beal, Juliana Rodrigues
    Dutra, Ana Carolina Pereira
    de Oliveira, Joao Bosco
    Araujo, Sergio Eduardo Alonso
    Uson, Pedro Luiz Serrano
    EINSTEIN-SAO PAULO, 2024, 22 : eAO0575
  • [46] Correlation between immunotherapy biomarker PD-L1 expression and genetic alteration in patients with non-small cell lung cancer
    Chen, Hefeng
    Ge, Mengxi
    Zhang, Fuchuang
    Xing, Yishi
    Yu, Shicheng
    Chen, Chunzhu
    Zhang, Hougang
    Wang, Xiaoyong
    Gao, Xing
    Chen, Fangtao
    Chen, Peilin
    Zhang, Dadong
    Zhan, Qiong
    Zhu, Youcai
    GENOMICS, 2023, 115 (04)
  • [47] Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer
    Cho, Jong Ho
    Zhou, Wei
    Choi, Yoon-La
    Sun, Jong-Mu
    Choi, Hyejoo
    Kim, Tae-Eun
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Rutkowski, Mary Anne
    Kim, Jhingook
    CANCER RESEARCH AND TREATMENT, 2018, 50 (01): : 95 - 102
  • [48] PD-L1 expression in paired non-small cell lung cancer tumor samples
    Kim, Jhingook
    Sorensen, Steffen Filskov
    Choi, Yoon-La
    Wang, Zhen
    Sun, Jong-Mu
    Choi, Hyejoo
    Georgsen, Jeanette Baehr
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Wu, Dianna Y.
    Meldgaard, Peter
    Zhou, Wei
    Hager, Henrik
    CANCER RESEARCH, 2015, 75
  • [49] Mutational landscapes and PD-L1 expression in non-small cell lung cancer.
    Zhang, Kang
    Wang, Guanghui
    Guo, Chao
    Chen, Xinyu
    Zhang, Shiyue
    Wang, Wenjing
    Yao, Ming
    Liu, Angen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Comparison of PD-L1 expression before and after neoadjuvant chemoradiation or chemotherapy in stage III non-small cell lung cancer (NSCLC)
    Koenig, D.
    Prince, S. Savic
    Trachsel, B.
    Hayoz, S.
    Pless, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1376 - S1376
12345